These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26577841)

  • 1. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
    Bombard Y
    Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
    [No Abstract]   [Full Text] [Related]  

  • 2. Translating genomics in cancer care.
    Bombard Y; Bach PB; Offit K
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1343-53. PubMed ID: 24225968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine.
    Borro M; Simmaco M; Aceti A; Barni S; De Luca A; Fineschi V; Frati P; Girardi P; Miozzo M; Nati G; Nicoletti F; Santini D; Marchetti P
    Curr Pharm Biotechnol; 2016; 17(10):926-9. PubMed ID: 27194357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
    Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
    Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward clinical genomics in everyday medicine: perspectives and recommendations.
    Delaney SK; Hultner ML; Jacob HJ; Ledbetter DH; McCarthy JJ; Ball M; Beckman KB; Belmont JW; Bloss CS; Christman MF; Cosgrove A; Damiani SA; Danis T; Delledonne M; Dougherty MJ; Dudley JT; Faucett WA; Friedman JR; Haase DH; Hays TS; Heilsberg S; Huber J; Kaminsky L; Ledbetter N; Lee WH; Levin E; Libiger O; Linderman M; Love RL; Magnus DC; Martland A; McClure SL; Megill SE; Messier H; Nussbaum RL; Palaniappan L; Patay BA; Popovich BW; Quackenbush J; Savant MJ; Su MM; Terry SF; Tucker S; Wong WT; Green RC
    Expert Rev Mol Diagn; 2016; 16(5):521-32. PubMed ID: 26810587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establish good genomic practice to guide medicine forward.
    Barker RW; Brindley DA; Schuh A
    Nat Med; 2013 May; 19(5):530. PubMed ID: 23652098
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
    Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
    Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
    Wilson BJ; Miller FA; Rousseau F
    J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized genome structure via single gamete sequencing.
    Lyu R; Tsui V; McCarthy DJ; Crismani W
    Genome Biol; 2021 Apr; 22(1):112. PubMed ID: 33874978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.
    Conti R; Veenstra DL; Armstrong K; Lesko LJ; Grosse SD
    Med Decis Making; 2010; 30(3):328-40. PubMed ID: 20086232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethical and social issues associated with genomic medicine].
    Barazzetti G; Kaufmann A; Benaroyo L
    Praxis (Bern 1994); 2014 May; 103(10):573-7. PubMed ID: 24800769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision Medicine: From Science To Value.
    Ginsburg GS; Phillips KA
    Health Aff (Millwood); 2018 May; 37(5):694-701. PubMed ID: 29733705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges.
    Tekola-Ayele F; Rotimi CN
    Public Health Genomics; 2015; 18(4):242-7. PubMed ID: 26138992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics.
    Johnson JA; Elsey AR; Clare-Salzler MJ; Nessl D; Conlon M; Nelson DR
    Pharmacogenomics; 2013 May; 14(7):723-6. PubMed ID: 23651020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Precision Medicine Can Learn from Rare Genetic Disease Research and Translation.
    Tabor HK; Goldenberg A
    AMA J Ethics; 2018 Sep; 20(9):E834-840. PubMed ID: 30242814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moral Duties of Genomics Researchers: Why Personalized Medicine Requires a Collective Approach.
    Vos S; van Delden JJM; van Diest PJ; Bredenoord AL
    Trends Genet; 2017 Feb; 33(2):118-128. PubMed ID: 28017398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential elements of personalized medicine.
    Burke W; Brown Trinidad S; Press NA
    Urol Oncol; 2014 Feb; 32(2):193-7. PubMed ID: 24321254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tensions in ethics and policy created by National Precision Medicine Programs.
    Minari J; Brothers KB; Morrison M
    Hum Genomics; 2018 Apr; 12(1):22. PubMed ID: 29665847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
    Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
    Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.